While we are able to differentiate embryonal versus alveolar histology for many rhabdomyosarcoma patients, other biological information such as N-MYC amplification for neuroblastoma patients or anaplastic histology for Wilms tumor patients were either unavailable or available for very few patients. Here, MYCN is linked to neuroblastoma.